Search Results for: Nucleix

Investment in Israeli startups (16/1/22)

BigPanda raised $190 million; Pentera raised $150 million; Placer.ai raised $100 million; MeMed raised $93 million; WEKA.io raised $73 million; Quris raised $28 million; Nucleix raised $22 million; Shield raised $15 million; Second Nature raised $12.5 million; Addon Optics raised … Continue reading

Posted in Economy & Business | Leave a comment

Investment in Israeli startups (25/4/21)

Innoviz raised $371 million; Redis raised $310 million; TipRanks raised $77 million; WhiteSource (renamed Mend.io) raised $75 million; RapidAPI raised $60 million; Nucleix raised $55 million; Blue Dot raised $32 million; Perception Point raised $28 million; Breezometer raised $25 million; … Continue reading

Posted in Economy & Business | Leave a comment

Blood test detects early-stage lung cancer

In tests, the Lung EpiCheck blood test developed by Israel’s Nucleix (reported here previously) detected 85% of early stage lung cancers among smokers and ex-smokers with a high risk for developing the disease. On low-risk individuals, the accuracy increased to … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

More European funds for Israeli cancer testing

I reported previously (see here) on Israel’s Nucleix and its innovative blood and urine tests for early-stage cancer diagnostics. Nucleix has just received a grant of 2.5 million Euros from the EU’s Horizon 2020 research and innovation program – its … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Europe approves Israeli bladder cancer test

I reported previously (Jun 2014) on the non-invasive urine test of Israel’s Nucleix for monitoring bladder cancer treatment. Following a multi-center, 400-patients clinical trial, Nucleix has received the CE Mark allowing it to market Bladder EpiCheck in the E.U. https://www.israel21c.org/bladder-cancer-monitor-gets-ce-mark-lung-cancer-test-next/

Posted in Israel's Medical Achievements | Leave a comment

Blood test for lung cancer

Israeli scientists from the Rehovot-based company Nucleix succeeded in developing a first of its kind blood test to diagnose lung cancer long before it spreads in the body, thus increasing the chance of survival. The test examines anomalies of the … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Non-invasive test for bladder cancer

Israeli biotech Nucleix has raised more than $5 million to finance its test for early detection of bladder cancer. Nucleix uses epigenetics (tiny changes in a cell’s DNA) to identify cancer cells. In the future, the product could also be … Continue reading

Posted in Israel's Medical Achievements | Leave a comment